We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AEHR's record effective backlog of about $100.6 million supports rising AI production requirements.
Camtek's advanced packaging generated roughly 75% of second-quarter 2026 revenues.
The semiconductor equipment industry is benefiting from rising AI and high-performance computing (HPC) investment, alongside growing advanced-packaging requirements. As device architectures become more sophisticated, chipmakers increasingly require specialized testing, inspection and metrology tools to support manufacturing quality and reliability.
Aehr Test Systems, Inc. (AEHR - Free Report) and Camtek Ltd. (CAMT - Free Report) both serve this specialized equipment market, but their exposure differs.Aehr is building greater AI and HPC exposure through wafer- and package-level test and burn-in solutions and has recently pointed to accelerating demand for AI-related wafer-level burn-in. Camtek, meanwhile, focuses on inspection and metrology systems used across semiconductor manufacturing, including advanced-packaging applications, giving the two companies distinct positions within the broader semiconductor capital-equipment value chain.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better bet now.
The Case for AEHR
Aehr entered fiscal 2027 with a much broader growth base than it had a few years ago. AI processors have emerged as the biggest driver, with reliability and production wafer-level burn-in for AI accelerators, CPUs and network processors accounting for about 71% of fiscal 2026 revenues. In the fourth quarter of fiscal 2026, its net revenues surged 33.7% year over year. The company expects fiscal 2027 revenues of $130-$150 million, or roughly 160%-200% growth, supported by a record effective backlog of about $100.6 million and rising production requirements from existing AI customers.
The opportunity is also broadening beyond Aehr’s current lead customers. A major AI processor supplier recently completed a successful FOX wafer-level burn-in benchmark and is moving toward pilot-production validation, while the lead wafer-level AI customer subsequently placed a $22 million follow-on order to expand production capacity. Aehr is simultaneously building silicon-photonics exposure as hyperscale data centers adopt faster optical interconnects, while GaN and memory represent additional longer-term opportunities. AEHR beat earnings estimates in three of the past four quarters and met once, with an average surprise of 321.9%.
Aehr Test Systems Price, Consensus and EPS Surprise
Aehr is scaling capacity to support a larger revenue base without adding excessive fixed infrastructure. Sonoma systems are now shipping from a Southeast Asian contract manufacturer with capacity for more than 20 systems per month, while Fremont and Taiwan operations have also been expanded. This flexible model could help Aehr meet uneven AI-driven demand while keeping fixed costs in check.
Product development is broadening Aehr’s addressable market. The enhanced Sonoma platform supports next-generation AI processors drawing 2,000 watts or more, while the FOX roadmap is expanding into NAND flash and HBM. Aehr is also working with multiple memory suppliers on solutions for next-generation high-bandwidth memory and flash applications, which could create another growth avenue.
The Case for CAMT
Camtek’s growth is increasingly tied to the build-out of advanced packaging for AI and high-performance computing. Advanced Packaging generated roughly 75% of second-quarter 2026 revenues, while year-to-date orders exceeded $600 million, with about 80% linked to advanced-packaging applications. Demand is being driven by HBM, 2.5D/3D packaging and CoWoS-like architectures.
The order profile provides visibility beyond the current year. More than half of the $600 million order intake came from OSAT customers, while more than 20% was tied to HBM players. Camtek also secured more than $105 million of multi-system orders from a tier-1 OSAT and a leading HBM manufacturer for delivery in 2027. This suggests that growth is being supported by both capacity additions and rising inspection intensity as advanced packages incorporate more dies, interconnects and increasingly demanding process steps.
CAMT is expanding its inspection and metrology reach through newer platforms. Hawk is gaining traction in HBM and other advanced-packaging applications, while Eagle G5 improves resolution, throughput and cost of ownership. Together, the two platforms generated about half of second-quarter systems revenues, while NanoProf broadens Camtek’s metrology capabilities into additional process steps.
Beyond hardware, CAMT is strengthening its software and AI capabilities. The Visual Layer acquisition strengthens Camtek’s visual-AI capabilities across its inspection and metrology offering, while new backside inspection and fluorescence technologies broaden its application reach. Photonics is also emerging as a growth area as silicon-photonics and compound-semiconductor demand expand. CAMT beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 1%.
However, Camtek remains exposed to China-related risks, including intensifying competition from domestic semiconductor-equipment suppliers and evolving export controls and trade restrictions. Rising receivables and inventory needs could also increase working-capital requirements as the company scales.
How Do Estimates Compare for AEHR & CAMT?
The consensus mark for AEHR’s fiscal 2027 earnings has increased by 4 cents to 74 cents per share over the past 30 days. The company reported earnings of 3 cents per share in fiscal 2026.
The Zacks Consensus Estimate for CAMT’s 2026 earnings is pegged at $3.60 per share, unchanged over the past 30 days, indicating a 10.4% increase over 2025’s reported figure.
Price Performance Comparison
In the year-to-date period, AEHR outperformed CAMT, the broader industry and the S&P 500 Index.
Price Performance – AEHR, CAMT, Industry & S&P 500
Image Source: Zacks Investment Research
Valuation: AEHR vs. CAMT
Coming to the valuation story, it seems that investors are willing to pay a premium for Aehr compared to CAMT. This is reflected in AEHR’s forward 12-month price/sales (P/S) of 19.81X compared with CAMT’s 9.88X.
Image Source: Zacks Investment Research
Conclusion
Both Aehr and Camtek are positioned to benefit from rising semiconductor complexity and AI-driven investment, but their growth profiles differ. Camtek offers broader exposure to advanced packaging, HBM and inspection/metrology, supported by a strong order pipeline and expanding product portfolio. Aehr, however, is entering a sharper growth phase as AI-related wafer-level and package-level burn-in demand accelerates, backed by a record backlog and a much higher fiscal 2027 revenue growth outlook.
The combination of rapid AI-related revenue expansion, capacity scaling and additional opportunities in silicon photonics, GaN and memory gives Aehr greater earnings-growth potential. AEHR appears more compelling at present, even though both AEHR and CAMT currently carry a Zacks Rank #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
AEHR vs. CAMT: Which Semiconductor Equipment Stock Is the Better Bet?
Key Takeaways
The semiconductor equipment industry is benefiting from rising AI and high-performance computing (HPC) investment, alongside growing advanced-packaging requirements. As device architectures become more sophisticated, chipmakers increasingly require specialized testing, inspection and metrology tools to support manufacturing quality and reliability.
Aehr Test Systems, Inc. (AEHR - Free Report) and Camtek Ltd. (CAMT - Free Report) both serve this specialized equipment market, but their exposure differs.Aehr is building greater AI and HPC exposure through wafer- and package-level test and burn-in solutions and has recently pointed to accelerating demand for AI-related wafer-level burn-in. Camtek, meanwhile, focuses on inspection and metrology systems used across semiconductor manufacturing, including advanced-packaging applications, giving the two companies distinct positions within the broader semiconductor capital-equipment value chain.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better bet now.
The Case for AEHR
Aehr entered fiscal 2027 with a much broader growth base than it had a few years ago. AI processors have emerged as the biggest driver, with reliability and production wafer-level burn-in for AI accelerators, CPUs and network processors accounting for about 71% of fiscal 2026 revenues. In the fourth quarter of fiscal 2026, its net revenues surged 33.7% year over year. The company expects fiscal 2027 revenues of $130-$150 million, or roughly 160%-200% growth, supported by a record effective backlog of about $100.6 million and rising production requirements from existing AI customers.
The opportunity is also broadening beyond Aehr’s current lead customers. A major AI processor supplier recently completed a successful FOX wafer-level burn-in benchmark and is moving toward pilot-production validation, while the lead wafer-level AI customer subsequently placed a $22 million follow-on order to expand production capacity. Aehr is simultaneously building silicon-photonics exposure as hyperscale data centers adopt faster optical interconnects, while GaN and memory represent additional longer-term opportunities. AEHR beat earnings estimates in three of the past four quarters and met once, with an average surprise of 321.9%.
Aehr Test Systems Price, Consensus and EPS Surprise
Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote
Aehr is scaling capacity to support a larger revenue base without adding excessive fixed infrastructure. Sonoma systems are now shipping from a Southeast Asian contract manufacturer with capacity for more than 20 systems per month, while Fremont and Taiwan operations have also been expanded. This flexible model could help Aehr meet uneven AI-driven demand while keeping fixed costs in check.
Product development is broadening Aehr’s addressable market. The enhanced Sonoma platform supports next-generation AI processors drawing 2,000 watts or more, while the FOX roadmap is expanding into NAND flash and HBM. Aehr is also working with multiple memory suppliers on solutions for next-generation high-bandwidth memory and flash applications, which could create another growth avenue.
The Case for CAMT
Camtek’s growth is increasingly tied to the build-out of advanced packaging for AI and high-performance computing. Advanced Packaging generated roughly 75% of second-quarter 2026 revenues, while year-to-date orders exceeded $600 million, with about 80% linked to advanced-packaging applications. Demand is being driven by HBM, 2.5D/3D packaging and CoWoS-like architectures.
The order profile provides visibility beyond the current year. More than half of the $600 million order intake came from OSAT customers, while more than 20% was tied to HBM players. Camtek also secured more than $105 million of multi-system orders from a tier-1 OSAT and a leading HBM manufacturer for delivery in 2027. This suggests that growth is being supported by both capacity additions and rising inspection intensity as advanced packages incorporate more dies, interconnects and increasingly demanding process steps.
CAMT is expanding its inspection and metrology reach through newer platforms. Hawk is gaining traction in HBM and other advanced-packaging applications, while Eagle G5 improves resolution, throughput and cost of ownership. Together, the two platforms generated about half of second-quarter systems revenues, while NanoProf broadens Camtek’s metrology capabilities into additional process steps.
Beyond hardware, CAMT is strengthening its software and AI capabilities. The Visual Layer acquisition strengthens Camtek’s visual-AI capabilities across its inspection and metrology offering, while new backside inspection and fluorescence technologies broaden its application reach. Photonics is also emerging as a growth area as silicon-photonics and compound-semiconductor demand expand. CAMT beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 1%.
Camtek Ltd. Price, Consensus and EPS Surprise
Camtek Ltd. price-consensus-eps-surprise-chart | Camtek Ltd. Quote
However, Camtek remains exposed to China-related risks, including intensifying competition from domestic semiconductor-equipment suppliers and evolving export controls and trade restrictions. Rising receivables and inventory needs could also increase working-capital requirements as the company scales.
How Do Estimates Compare for AEHR & CAMT?
The consensus mark for AEHR’s fiscal 2027 earnings has increased by 4 cents to 74 cents per share over the past 30 days. The company reported earnings of 3 cents per share in fiscal 2026.
The Zacks Consensus Estimate for CAMT’s 2026 earnings is pegged at $3.60 per share, unchanged over the past 30 days, indicating a 10.4% increase over 2025’s reported figure.
Price Performance Comparison
In the year-to-date period, AEHR outperformed CAMT, the broader industry and the S&P 500 Index.
Price Performance – AEHR, CAMT, Industry & S&P 500
Image Source: Zacks Investment Research
Valuation: AEHR vs. CAMT
Coming to the valuation story, it seems that investors are willing to pay a premium for Aehr compared to CAMT. This is reflected in AEHR’s forward 12-month price/sales (P/S) of 19.81X compared with CAMT’s 9.88X.
Image Source: Zacks Investment Research
Conclusion
Both Aehr and Camtek are positioned to benefit from rising semiconductor complexity and AI-driven investment, but their growth profiles differ. Camtek offers broader exposure to advanced packaging, HBM and inspection/metrology, supported by a strong order pipeline and expanding product portfolio. Aehr, however, is entering a sharper growth phase as AI-related wafer-level and package-level burn-in demand accelerates, backed by a record backlog and a much higher fiscal 2027 revenue growth outlook.
The combination of rapid AI-related revenue expansion, capacity scaling and additional opportunities in silicon photonics, GaN and memory gives Aehr greater earnings-growth potential. AEHR appears more compelling at present, even though both AEHR and CAMT currently carry a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.